Literature DB >> 20815775

Dietary modulation of oxidative stress in chronic obstructive pulmonary disease patients.

Jordi de Batlle1, Esther Barreiro, Isabelle Romieu, Michelle Mendez, Federico P Gómez, Eva Balcells, Jaume Ferrer, Mauricio Orozco-Levi, Joaquim Gea, Josep M Antó, Judith Garcia-Aymerich.   

Abstract

A total of 267 clinically stable chronic obstructive pulmonary disease (COPD) patients provided complete data about diet and oxidative stress markers in order to assess the relationship between antioxidant rich food groups and nutrients, and serum markers of oxidative stress in COPD. Dietary data of the last 2 years was assessed using a validated food frequency questionnaire (122 items). Levels of carbonyls, nitrotyrosine, malondialdehyde and reduced glutathione (GSH) were measured in serum. Vitamin E intake was inversely associated with levels of carbonyls (p = 0.05) and olive oil was positively associated with GSH levels (p = 0.01), in active smokers. Intake of vegetables was related to a decrease of malondialdehyde levels (p = 0.04) in former smokers. No statistically significant associations were found between remaining dietary antioxidants and serum oxidative stress markers. These results provide new data for a potential dietary modulation of systemic oxidative stress in COPD patients, particularly in those that continue smoking.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20815775     DOI: 10.3109/10715762.2010.500667

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  8 in total

Review 1.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

2.  Nutrition as a modifiable factor in the onset and progression of pulmonary function impairment in COPD: a systematic review.

Authors:  Lieke E J van Iersel; Rosanne J H C G Beijers; Harry R Gosker; Annemie M W J Schols
Journal:  Nutr Rev       Date:  2022-05-09       Impact factor: 6.846

3.  Hhip haploinsufficiency sensitizes mice to age-related emphysema.

Authors:  Taotao Lao; Zhiqiang Jiang; Jeong Yun; Weiliang Qiu; Feng Guo; Chunfang Huang; John Dominic Mancini; Kushagra Gupta; Maria E Laucho-Contreras; Zun Zar Chi Naing; Li Zhang; Mark A Perrella; Caroline A Owen; Edwin K Silverman; Xiaobo Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-21       Impact factor: 11.205

Review 4.  Influence of diet and obesity on COPD development and outcomes.

Authors:  Corrine Hanson; Erica P Rutten; Emiel F M Wouters; Stephen Rennard
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-08-05

5.  Dietary ω-6 polyunsaturated fatty acid arachidonic acid increases inflammation, but inhibits ECM protein expression in COPD.

Authors:  Sandra Rutting; Michael Papanicolaou; Dia Xenaki; Lisa G Wood; Alexander M Mullin; Philip M Hansbro; Brian G Oliver
Journal:  Respir Res       Date:  2018-11-03

6.  Dietary phenotype and advanced glycation end-products predict WTC-obstructive airways disease: a longitudinal observational study.

Authors:  Rachel Lam; Sophia Kwon; Jessica Riggs; Maria Sunseri; George Crowley; Theresa Schwartz; Rachel Zeig-Owens; Hilary Colbeth; Allison Halpren; Mengling Liu; David J Prezant; Anna Nolan
Journal:  Respir Res       Date:  2021-01-18

Review 7.  Tocotrienols: Dietary Supplements for Chronic Obstructive Pulmonary Disease.

Authors:  Xiangming Ji; Hongwei Yao; Maureen Meister; Douglas S Gardenhire; Huanbiao Mo
Journal:  Antioxidants (Basel)       Date:  2021-05-31

8.  Trolox contributes to Nrf2-mediated protection of human and murine primary alveolar type II cells from injury by cigarette smoke.

Authors:  E M Messier; K Bahmed; R M Tuder; H W Chu; R P Bowler; B Kosmider
Journal:  Cell Death Dis       Date:  2013-04-04       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.